参考文献/References:
[1] Gorelick PB. The global burden of stroke: persistent and disabling[J]. Lancet Neurol, 2019, 18(5): 417-418.
[2] Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia[J]. Biochim Biophys Acta, 2016, 1862(5): 915-925.
[3] 董强,郭起浩,罗本燕,等.卒中后认知障碍管理专家共识[J].中国卒中杂志,2017,12(6):519-531.
[4] Weisel JW, Litvinov RI. Fibrin formation, structure and properties[J]. Subcell Biochem, 2017, 82: 405-456.
[5] Undas A, Ari?s RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases[J]. Arterioscler Thromb Vasc Biol, 2011, 31(12): e88-e99.
[6] Rybarczyk BJ, Lawrence SO, Simpson-Haidaris PJ. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration[J]. Blood, 2003, 102(12): 4035-4043.
[7] Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease[J]. Semin Immunopathol, 2012, 34(1): 43-62.
[8] Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders[J]. Nat Rev Neurol, 2018, 14(3): 133-150.
[9] Jiang X, Andjelkovic AV, Zhu L, et al. Blood-brain barrier dysfunction and recovery after ischemic stroke[J]. Prog Neurobiol, 2018, 163-164: 144-171.
[10] Liu YT, Chen HJ, Kai Z, et al. High levels of plasma fibrinogen are related to post‐stroke cognitive impairment[J]. Brain Behav, 2019, 9(10): e01391.
[11] Muradashvili N, Qipshidze N, Munjal C, et al. Fibrinogen-induced increased pial venular permeability in mice[J]. J Cereb Blood Flow Metab, 2012, 32(1): 150-163.
[12] Ryu JK, Petersen M, Murray SG, et al. Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation[J]. Nat Commun, 2015, 6: 8164.
[13] Petersen M, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics[J]. Nat Rev Neurosci, 2018, 19(5): 283-301.
[14] Zhang W, Mi Y, Jiao K, et al. Kellerin alleviates cognitive impairment in mice after ischemic stroke by multiple mechanisms[J]. Phytother Res, 2020, 34(9): 2258-2274.
[15] Kim H, Seo JS, Lee SY, et al. AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice[J]. Brain Behav Immun, 2020, 87: 765-776.
[16] Hansen DV, Hanson JE, Sheng M. Microglia in alzheimer’s disease[J]. J Cell Biol, 2018, 217(2): 459-472.
[17] Jolivel V, Bicker F, Binamé F, et al. Perivascular microglia promote blood vessel disintegration in the ischemic penumbra[J]. Acta Neuropathol, 2015, 129(2): 279-295.
[18] Ryu JK, Rafalski VA, Meyer-Franke A, et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration[J]. Nat Immunol, 2018, 19(11): 1212-1223.
[19] Halder SK, Milner R. A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord[J]. Proc Natl Acad Sci U S A, 2019, 116(51): 26029-26037.
[20] Merlini M, Rafalski VA, Rios CP, et al. Fibrinogen induces Microglia-Mediated spine elimination and cognitive impairment in an alzheimer’s disease model[J]. Neuron, 2019, 101(6): 1099-1108.e6.
[21] Price BR, Norris CM, Sompol PA. An emerging role of astrocytes in vascular contributions to cognitive impairment and dementia[J]. J Neurochem, 2018, 144(5, SI): 644-650.
[22] Santello M, Toni N, Volterra A. Astrocyte function from information processing to cognition and cognitive impairment[J]. Nat Neurosci, 2019, 22(2): 154-166.
[23] Phatnani H, Maniatis T. Astrocytes in neurodegenerative disease[J]. Cold Spring Harb Perspect Biol, 2015, 7(6): a020628.
[24] Clark VD, Layson A, Charkviani M, et al. Hyperfibrinogenemia-mediated astrocyte activation[J]. Brain Res, 2018, 1699: 158-165.
[25] Colombo E, Cordiglieri C, Melli G, et al. Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration[J]. J Exp Med, 2012, 209(3): 521-535.
[26] Huang L, Wu ZB, Zhuge Q, et al. Glial scar formation occurs in the human brain after ischemic stroke[J]. Int J Med Sci, 2014, 11(4): 344-348.
[27] Raposo C, Schwartz M. Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries[J]. Glia, 2014, 62(11): 1895-1904.
[28] Dossi E, Vasile F, Rouach N. Human astrocytes in the diseased brain[J]. Brain Res Bull, 2018, 136: 139-156.
[29] Schachtrup C, Ryu JK, Helmrick MJ, et al. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage[J]. J Neurosci, 2010, 30(17): 5843-5854.
[30] Okamoto Y, Yamamoto T, Kalaria RN, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts[J]. Acta Neuropathol, 2012, 123(3): 381-394.
[31] Nguyen TV, Hayes M, Zbesko JC, et al. Alzheimer’s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia[J]. Acta Neuropathol Commun, 2018, 6(1): 100.
[32] Garcia-Alloza M, Gregory J, Kuchibhotla KV, et al. Cerebrovascular lesions induce transient β-amyloid deposition[J]. Brain, 2011, 134(Pt 12): 3697-3707.
[33] Goulay R, Mena RL, Hol EM, et al. From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-β formation[J]. Transl Stroke Res, 2020, 11(4): 601-614.
[34] Cortes-Canteli M, Mattei L, Richards AT, et al. Fibrin deposited in the Alzheimer’s disease brain promotes neuronal degeneration[J]. Neurobiol Aging, 2015, 36(2): 608-617.
[35] Zamolodchikov D, Berk-Rauch H, Da, et al. Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen[J]. Blood, 2016, 128(8): 1144-1151.
[36] Zamolodchikov D, Strickland S. Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin[J]. Blood, 2012, 119(14): 3342-3351.
[37] Ahn HJ, Chen ZL, Zamolodchikov D, et al. Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII May contribute to Alzheimer’s disease[J]. Curr Opin Hematol, 2017, 24(5): 427-431.
[38] Ill-Raga G, Palomer E, Ramos-Fernández E, et al. Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death[J]. Biochim Biophys Acta, 2015, 1852(3): 421-428.
[39] Martí-Fàbregas J, Valencia C, Pujol J, et al. Fibrinogen and the amount of leukoaraiosis in patients with symptomatic small-vessel disease[J]. Eur Neurol, 2002, 48(4): 185-190.